Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Newron Pharmaceuticals Spa. | NP5 | Nov 18, 2024 | 7.47 | -5.92 |
News Corp | NC0E | Nov 18, 2024 | 30.20 | 0.00 |
News Corporation - Class A | NC0 | Nov 18, 2024 | 27.00 | -0.74 |
News Corporation - Class B | NC0B | Nov 18, 2024 | 29.60 | 0.00 |
Newtek Business Services Corp. | 1N31 | Nov 18, 2024 | 13.24 | +0.46 |
NEWTON RES | 8NW | Nov 18, 2024 | 0.03 | 0.00 |
Nexa Resources S.A. | NE0 | Nov 18, 2024 | 7.20 | -0.69 |
Nexam Chemical Holding | NC4 | Nov 18, 2024 | 0.30 | +0.33 |
NEXANS ADR EO 1 | NXS0 | Nov 18, 2024 | 54.50 | -2.68 |
Nexans SA | NXS | Nov 18, 2024 | 111.30 | +0.09 |
NEXE Innovations Inc | NX5 | Nov 18, 2024 | 0.28 | +4.94 |
NexGen Energy Ltd | 6NE | Nov 18, 2024 | 7.50 | +7.33 |
NexGen Energy Ltd | 6NEA | Nov 18, 2024 | 6.80 | +3.03 |
NEXI S.P.A. Unsponsored ADR (Italy) | N0X0 | Nov 18, 2024 | 5.05 | -1.94 |
Nexi SpA | N0XA | Nov 18, 2024 | 5.38 | -0.77 |
Nexity SA | NQ9 | Nov 18, 2024 | 12.52 | +0.16 |
NEXLIVING CMNTYS INC. | NMX0 | Nov 18, 2024 | 1.49 | +6.43 |
Nexon Co Ltd | 7NX | Nov 18, 2024 | 12.20 | 0.00 |
NEXON CO.LTD ADR | 7NX0 | Nov 18, 2024 | 11.70 | -4.10 |
NexPoint Residential Trust, Inc. | 5O4 | Nov 18, 2024 | 42.00 | +0.96 |
NeXR Technologies SE | NXR | Nov 18, 2024 | 0.01 | +16.67 |
Nexstar Media Group, Inc. - Class A | NXZ | Nov 18, 2024 | 153.60 | -0.07 |
Nexstim | 5NX | Nov 18, 2024 | 5.00 | +3.09 |
NEXT Biometrics Group | NT7 | Nov 18, 2024 | 0.59 | -2.33 |
Next EQ | R87 | Nov 18, 2024 | 0.85 | 0.00 |
Next Fifteen Communications Group plc | 8LS | Nov 18, 2024 | 4.32 | -5.26 |
NEXT GEOSOLUTIONS EUROPE | LV8 | Nov 18, 2024 | 7.27 | -4.22 |
NEXT LS-,10 UNSP.ADR 1/2 | NXG0 | Nov 18, 2024 | 56.50 | -0.88 |
Next PLC | NXG | Nov 18, 2024 | 114.40 | -0.35 |
NextCell Pharma AB | 65G | Nov 18, 2024 | 0.11 | -0.87 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.